Project Summary
Functional gastrointestinal (GI) disorders such as chronic constipation, functional dyspepsia and irritable bowel
syndrome (IBS) are highly prevalent but have few definitive treatments. IBS alone affects more than 10% of the
U.S. population, causing chronic abdominal pain and altered GI motility leading to debilitating diarrhea and/or
constipation. Prominent sex differences have been noted in IBS; men and women often present with different
symptoms and exhibit different responses to treatment. Identifying the underlying basis of these sex
differences will lead to more effective and personalized treatments for IBS. The enteric nervous system (ENS),
which consists of the intrinsic nerve circuits of the bowel, is essential for regulating GI motility. Cellular,
molecular, or circuit-level sex differences in the ENS may underlie sex differences in IBS, but this has been not
been well studied. We have evidence that dysfunction in glial cells, the non-neuronal cells of the ENS, leads to
a sexually dimorphic effect on colonic motility, and that enteric glia express receptors for sex hormones. The
research objectives of this project are thus to determine: (1) how ongoing exposure to gonadal sex hormones,
such as testosterone and estrogen, regulates colonic motility, and (2) how glia interact with intrinsic sensory
neurons in the ENS to regulate colonic motility in a sex-dependent manner. Over the course of this 5 year
career development award, the principal investigator will build upon her previous clinical training in
gastroenterology as well as her strong research background in neuroscience, to gain new skills in studying sex
differences in the ENS and adapting novel technologies to measuring neuronal activity in the bowel. These
skills will be applied to a series of in vivo and ex vivo experiments in mouse genetic models, which are
designed to test the hypothesis that sexual dimorphism in neuron-glia interactions within the ENS underlies sex
differences in GI motility and functional disease. Successful completion of this project will shed new light on
cellular mechanisms of sex differences in GI motility, and provide the principal investigator with the training and
experience she needs to launch her independent research program in enteric neurobiology.
Public Health Relevance Statement
Project Narrative
Functional gastrointestinal (GI) disorders such as irritable bowel syndrome (IBS) are among the most common,
but least understood of all digestive disorders. Functional disorders have remarkably different symptoms and
responses to treatment in men and women, but the reasons for these sex differences remain unclear. Learning
how the intrinsic nerve circuits of the bowel, which are important for regulating GI motility, differ between males
and females, will lead to more effective treatments for IBS and other functional GI conditions.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
076593722
UEI
Z1L9F1MM1RY3
Project Start Date
29-August-2016
Project End Date
31-May-2021
Budget Start Date
12-October-2018
Budget End Date
31-May-2019
Project Funding Information for 2018
Total Funding
$110,526
Direct Costs
$102,339
Indirect Costs
$8,187
Year
Funding IC
FY Total Cost by IC
2018
National Institute of Diabetes and Digestive and Kidney Diseases
$110,526
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 7K08DK110532-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 7K08DK110532-04
Patents
No Patents information available for 7K08DK110532-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 7K08DK110532-04
Clinical Studies
No Clinical Studies information available for 7K08DK110532-04
News and More
Related News Releases
No news release information available for 7K08DK110532-04
History
No Historical information available for 7K08DK110532-04
Similar Projects
No Similar Projects information available for 7K08DK110532-04